What type of medication is given in the BAN2401 Study - First Choice Neurology - Dr. Jeffrey Gelblum

Dr. Jeffrey Gelblum, Neurologist at First Choice Neurology, talks about the medication that is given to patients in the BAN2401 Study.

Patients will receive an infusion treatment every week for several months. They will be monitored to see if the treatments have a beneficial impact on dementia.

For additional information about the BAN2401 Study, visit

BAN2401 Study,First Choice Neurology,Dr. Jeffrey Gelblum,Infusion treatments,BAN2401 infusion treatment,Alzheimer's research,Early Alzheimer's disease,Questions about BAN2401 Study,Neurology,Alzheimer's,Alzheimer's disease,